NDC 49281-726 – Flublok Trivalent Northern Hemisphere
Influenza A Virus A/missouri/11/2025 (h1n1) Recombinant Hemagglutinin Antigen 45 ug/.5mL; Influenza A Virus A/darwin/1415/2025 (h3n2) Recombinant Hemagglutinin… · Injection · Intramuscular
Product NDC49281-726
Product details
- Brand name
- Flublok Trivalent Northern Hemisphere
- Generic name
- INFLUENZA A VIRUS A/Missouri/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Darwin/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/Pennsylvania/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- Injection
- Route
- Intramuscular
- Marketing category
- BLA · BLA125285
- Marketed since
- July 2, 2026
- Marketing end
- June 30, 2027
Active ingredients
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49281-726-10 | 10 SYRINGE in 1 CARTON (49281-726-10) / .5 mL in 1 SYRINGE (49281-726-88) | Jul 2, 2026 |